Chronic diseases: Perceptions about Covid-19 risk and vaccination
Ricotta, E. E.; Kwan, J. L.; Smith, B. A.; Evans, N. G.
Show abstract
BackgroundCOVID-19 disproportionately affects those with preexisting conditions, but little research has determined whether those with chronic diseases view the pandemic itself differently - and whether there are differences between chronic diseases. We theorized that while individuals with respiratory disease or autoimmune disorders would perceive greater threat from COVID-19 and be more supportive of non-pharmaceutical interventions (NPIs), those with autoimmune disorders would be less likely to support vaccination-based interventions. MethodsWe conducted a two-wave online survey conducted in February and November 2021 asking respondents their beliefs about COVID-19 risk perception, adoption and support of interventions, willingness to be vaccinated against COVID-19, and reasons for vaccination. Regression analysis was conducted to assess the relationship of respondents reporting a chronic disease and COVID-19 behaviors and attitudes, compared to healthy respondents adjusting for demographic and political factors. ResultsIn the initial survey, individuals reporting a chronic disease had stronger both stronger feelings of risk from COVID-19 as well as preferences for NPIs than healthy controls. The only NPI that was still practiced significantly more compared to healthy controls in the resample was limiting trips outside of the home. Support for community-level NPIs was higher among individuals reporting a chronic disease than healthy controls and remained high among those with respiratory diseases in sample 2. Vaccine acceptance produced more divergent results: those reporting chronic respiratory diseases were 6% more willing to be vaccinated than healthy controls, while we found no significant difference between individuals with autoimmune diseases and healthy controls. Respondents with chronic respiratory disease and those with autoimmune diseases were more likely to want to be vaccinated to protect themselves from COVID-19, and those with an autoimmune disease were more likely to report fear of a bad vaccine reaction as the reason for vaccine hesitancy. In the resample, neither those with respiratory diseases nor autoimmune diseases reported being more willing to receive a booster vaccine than healthy controls. ConclusionsIt is not enough to recognize the importance of health in determining attitudes: nuanced differences between conditions must also be recognized.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy in a massive online survey of US adults: January-May 2021 95%
- Strategies that make vaccination easy and promote autonomy could increase COVID-19 vaccination in those who remain hesitant 94%
- COVID-19 Vaccine Hesitancy in Underserved Communities of North Carolina 94%
Similar papers in this journal
- Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season 94%
- COVID-19 Vaccine Perceptions and Uptake in a National Prospective Cohort of Essential Workers 94%
- Employer Requirements and COVID-19 Vaccination and Attitudes among Healthcare Personnel in the U.S.: Findings from National Immunization Survey Adult COVID Module, August – September 2021 94%
Similar papers in this journal
- Race-ethnicity and Perceptional Determinants of COVID-19 Vaccination Intentions: A Cross-sectional Study Among Health Workers and the General Population in the San Francisco Bay Area 94%
- COVID-19 vaccination acceptance among healthcare workers in Germany 93%
- Predictors of COVID-19 Vaccine Hesitancy: Socio-demographics, Co-Morbidity and Past Experience of Racial Discrimination 93%
Similar papers in this journal
- COVID-19 Vaccine Perceptions And Differences By Sex, Age, And Education: Findings From A Cross-Sectional Assessment Of 1367 Community Adults In Ontario 92%
- Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results from Phase I of the Texas Coronavirus Antibody REsponse Survey (TX CARES) 92%
- Clinical And Serological Predictors Of Post COVID-19 Condition – Findings From A Canadian Prospective Cohort Study 92%
Similar papers in this journal
- Intention to receive a COVID-19 vaccine: Results from a population-based survey in Canada 93%
- Transition to Endemic: Acceptance of Additional COVID-19 Vaccine Doses Among Canadian Adults in A National Cross-Sectional Survey 93%
- Cumulative Social Disadvantage and Health-Related Quality of Life: National Health Interview Survey 2013-2017 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.